Prospective, Randomized Study of 2 Different Wound Dressings
Launched by UNIVERSITY OF COLOGNE · Nov 13, 2013
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
A monocentre, post CE-mark, randomized clinical trial will be conducted at the University of Cologne, Department of Orthopedics and Trauma Surgery.
Male or female subjects, 18 years and above, undergoing hip, knee or spinal surgery with an expected hospital stay for 4 days or more will be included in the trial. Individual trial duration will be for 7 days (follow-up).
Two hundred subjects will be included in the trial, i.e. 100 subjects per arm. The treatment arm (either new or standard wound dressing) will be assigned by randomization stratified by type of surgery (i.e. hip, knee or spin...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age ≥18years
- • 2. Have an expected total length of stay of 4 or more days
- • 3. Undergoing elective primary arthroplasty of the hip or knee or spinal surgery
- • 4. Undergoing hip surgery with a standard access
- • 5. Give their written informed consent to participate
- Exclusion Criteria:
- • 1. Dressing size does not fit the incision area
- • 2. Known allergy/hypersensitivity to any of the components of the dressing
- • 3. Multi-trauma
- • 4. Undergoing arthroplasty or spine surgery due to tumour or infection?
- • 5. Fractures
- • 6. Wound at the surgical site prior to surgery
- • 7. Neurological deficit of operated side (hemiplegia, etc.)
- • 8. Subject has documented skin disease at time of enrolment, as judged by the investigator
About University Of Cologne
The University of Cologne, a prestigious institution located in Germany, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive academic resources and expertise to design and conduct innovative studies aimed at improving patient care and health outcomes. With a focus on collaboration across various disciplines, the University of Cologne emphasizes rigorous scientific methodologies and ethical standards in its clinical research initiatives, contributing significantly to the global medical community and fostering the development of new therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cologne, , Germany
Patients applied
Trial Officials
Jan Bredow, physician
Principal Investigator
University Hospital of Cologne
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials